VREOF (Vireo Growth) Cyclically Adjusted FCF per Share: $-9.20 (As of Mar. 2026)


VREOF Vireo Growth Inc VREOF
46 GF Score
Price $10.11
GF Value $9.69
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Vireo Growth Cyclically Adjusted FCF per Share?

Vireo Growth VREOF +1.28% 46 Cyclically Adjusted FCF per Share is $-9.20 as of Mar. 2026. GuruFocus rates VREOF with a GF Score™ of 46/100 and a GF Value™ of $9.69 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Vireo Growth's adjusted free cash flow per share for the three months ended in Mar. 2026 was $0.017. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-9.20 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 18.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 25.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 22.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Vireo Growth was 35.70% per year. The lowest was 9.30% per year. And the median was 18.00% per year.

As of today (2026-07-08), Vireo Growth's current stock price is $10.1075. Vireo Growth's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-9.20. Vireo Growth's Cyclically Adjusted Price-to-FCF of today is .


Vireo Growth  (OTCPK:VREOF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Vireo Growth Cyclically Adjusted FCF per Share Related Terms


Vireo Growth Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Vireo Growth's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vireo Growth Cyclically Adjusted FCF per Share Chart

Vireo Growth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.37 -17.36 -11.40 -8.87 -9.48

Vireo Growth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.29 -9.27 -9.20 -9.48 -9.20

VREOF vs ZTS, UTHR: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vireo Growth Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Cyclically Adjusted Price-to-FCF falls into.


VREOF
46GF Score
Vireo Growth Inc VREOF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vireo Growth Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vireo Growth's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.017/330.2130*330.2130
=0.017

Current CPI (Mar. 2026) = 330.2130.

Vireo Growth Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.091 241.018 0.125
201609 -0.091 241.428 -0.124
201612 -10.000 241.432 -13.677
201703 -1.091 243.801 -1.478
201706 -0.364 244.955 -0.491
201709 -0.182 246.819 -0.243
201712 -6.588 246.524 -8.824
201803 -0.143 249.554 -0.189
201806 -0.857 251.989 -1.123
201809 -2.381 252.439 -3.115
201812 -0.381 251.233 -0.501
201903 -1.479 254.202 -1.921
201906 -10.711 256.143 -13.808
201909 -13.949 256.759 -17.940
201912 -1.428 256.974 -1.835
202003 -1.098 258.115 -1.405
202006 -1.715 257.797 -2.197
202009 -1.516 260.280 -1.923
202012 -1.388 260.474 -1.760
202103 -2.557 264.877 -3.188
202106 -4.450 271.696 -5.408
202109 -2.098 274.310 -2.526
202112 -2.643 278.802 -3.130
202203 -2.092 287.504 -2.403
202206 -1.132 296.311 -1.262
202209 -0.732 296.808 -0.814
202212 -1.578 296.797 -1.756
202303 -0.935 301.836 -1.023
202306 -0.151 305.109 -0.163
202309 0.087 307.789 0.093
202312 -0.585 306.746 -0.630
202403 -0.438 312.332 -0.463
202406 -0.668 314.175 -0.702
202409 -1.114 315.301 -1.167
202412 -1.179 315.605 -1.234
202503 -0.368 319.799 -0.380
202506 -0.471 322.561 -0.482
202509 -0.669 324.800 -0.680
202512 0.238 324.054 0.243
202603 0.017 330.213 0.017

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-9.20 mean?
Vireo Growth (VREOF) has a Cyclically Adjusted FCF per Share of $-9.20 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Vireo Growth and its competitors.
Is Vireo Growth's Cyclically Adjusted FCF per Share too high?
Vireo Growth's current Cyclically Adjusted FCF per Share is $-9.20. Overall, Vireo Growth has a GF Score™ of 46/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vireo Growth's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Vireo Growth's Cyclically Adjusted FCF per Share of $-9.20 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Vireo Growth and its competitors. Vireo Growth's current Cyclically Adjusted FCF per Share is $-9.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vireo Growth stock overvalued right now?
Based on GuruFocus' analysis, Vireo Growth (VREOF) is currently considered Fairly Valued. The stock's GF Value™ is $9.69, compared to a current price of $10.11 — trading 4.3% above its estimated fair value. The current Cyclically Adjusted FCF per Share is $-9.20. Vireo Growth's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Vireo Growth (VREOF), the current Cyclically Adjusted FCF per Share is $-9.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vireo Growth (VREOF) Overvalued in 2026?

Based on GuruFocus' analysis, Vireo Growth stock appears to be overvalued. The current stock price of $10.11 is trading 4.3% above its estimated GF Value™ of $9.69. GuruFocus considers Vireo Growth to be Fairly Valued.

Key valuation signals for VREOF:

  • Cyclically Adjusted FCF per Share: $-9.20
  • GF Value™: $9.69 vs. price of $10.11 (4.3% above fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the VREOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vireo Growth Business Description

Other Exchanges K95:GermanyVREO:Canada
Address 207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Incis a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. The company operates in one single segment.
46GF Score

Get the complete analysis for VREOF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.11
Price
$9.69
GF Value